Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Putative mechanisms of the relationship between obesity and migraine progression.

Literature DB >> 18796271

Putative mechanisms of the relationship between obesity and migraine progression.

Abstract

Studies suggest that obesity is associated with migraine progression from an episodic into a chronic form. We discuss putative mechanisms to justify this relationship. Several of the inflammatory mediators that are increased in obese individuals are important in migraine pathophysiology, including interleukins and calcitonin gene-related peptide. Both migraine and obesity are prothrombotic states. Substances that are important in metabolic control are nociceptive at certain levels. Hypothalamic dysfunction in the orexin pathways seems to be a risk factor for both conditions. In addition, we discuss the importance of metabolic syndrome and autonomic dysfunction in modulating the obesity/migraine progression relationship.

Entities: Disease Gene

Mesh：

Year: 2008 PMID： 18796271 DOI： 10.1007/s11916-008-0036-z

Source DB: PubMed Journal: Curr Pain Headache Rep ISSN： 1534-3081

46 in total

1. The emerging anti-inflammatory role of HDL-cholesterol, illustrated in cardiovascular disease free population; the ATTICA study.

Authors: Christina Chrysohoou; Christos Pitsavos; John Skoumas; Constantina Masoura; Anastasia Katinioti; Demosthenes Panagiotakos; Christodoulos Stefanadis
Journal: Int J Cardiol Date: 2006-12-22 Impact factor: 4.164

2. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.

Authors: P R Holland; S Akerman; P J Goadsby
Journal: J Pharmacol Exp Ther Date: 2005-09-13 Impact factor: 4.030

3. Midlife body mass index and hospitalization and mortality in older age.

Authors: Lijing L Yan; Martha L Daviglus; Kiang Liu; Jeremiah Stamler; Renwei Wang; Amber Pirzada; Daniel B Garside; Alan R Dyer; Linda Van Horn; Youlian Liao; James F Fries; Philip Greenland
Journal: JAMA Date: 2006-01-11 Impact factor: 56.272

4. Obesity is a risk factor for transformed migraine but not chronic tension-type headache.

Authors: Marcelo E Bigal; Richard B Lipton
Journal: Neurology Date: 2006-07-25 Impact factor: 9.910

5. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China.

Authors: Y Wang; J Mi; X-Y Shan; Q J Wang; K-Y Ge
Journal: Int J Obes (Lond) Date: 2006-05-02 Impact factor: 5.095

6. C-reactive protein may be increased in migraine patients who present with complex clinical features.

Authors: K M A Welch; Avery W Brandes; Lauren Salerno; Jan Lewis Brandes
Journal: Headache Date: 2006-02 Impact factor: 5.887

Review 7. Neurogenic inflammation in the pathophysiology and treatment of migraine.

Authors: M A Moskowitz
Journal: Neurology Date: 1993-06 Impact factor: 9.910

Review 8. Obesity, migraine, and chronic migraine: possible mechanisms of interaction.

Authors: Marcelo E Bigal; Richard B Lipton; Philip R Holland; Peter J Goadsby
Journal: Neurology Date: 2007-05-22 Impact factor: 9.910

9. Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area.

Authors: T Bartsch; M J Levy; Y E Knight; P J Goadsby
Journal: Pain Date: 2004-06 Impact factor: 6.961

Review 10. Hypocretin (orexin): role in normal behavior and neuropathology.

Authors: Jerome M Siegel
Journal: Annu Rev Psychol Date: 2004 Impact factor: 24.137

9 in total

Review 1. Obesity and chronic daily headache.

Authors: Marcelo E Bigal; Alan M Rapoport
Journal: Curr Pain Headache Rep Date: 2012-02

Putative mechanisms of the relationship between obesity and migraine progression.

1. The emerging anti-inflammatory role of HDL-cholesterol, illustrated in cardiovascular disease free population; the ATTICA study.

2. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.

3. Midlife body mass index and hospitalization and mortality in older age.

4. Obesity is a risk factor for transformed migraine but not chronic tension-type headache.

5. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China.

6. C-reactive protein may be increased in migraine patients who present with complex clinical features.

Review 7. Neurogenic inflammation in the pathophysiology and treatment of migraine.

Review 8. Obesity, migraine, and chronic migraine: possible mechanisms of interaction.

9. Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area.

Review 10. Hypocretin (orexin): role in normal behavior and neuropathology.

Review 1. Obesity and chronic daily headache.

Review 2. Association Between Obesity and Migraine in Women.

Review 3. Epidemiological association between migraine and lipoprotein(a): a systematic review.

Review 4. Migraine and cardiovascular disease: possible mechanisms of interaction.

Review 5. Dietary considerations in migraine management: does a consistent diet improve migraine?

Review 6. Chronic migraine plus medication overuse headache: two entities or not?

Review 7. Migraine and body mass index categories: a systematic review and meta-analysis of observational studies.

8. Allostatic Load in Perimenopausal Women With Migraine.

9. Genetic variants in migraine: a field synopsis and systematic re-analysis of meta-analyses.